国药控股(01099.HK) 公布,附属国药一致(000028.SZ) 发盈警,预计2024年度盈利介乎5.61亿至7.6亿人民币,按年下降52.5%-64.9%。年内,国药一致拟计提的商誉及无形资产减值准备金约8.76亿至10.7亿人币,将减少净利润5.05亿至6.18亿人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-17 16:25。) (A股报价延迟最少十五分钟。)
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/10/28 | 第三季业绩 | 无派息 |
2024/08/26 | 中期业绩 | 无派息 |
2024/04/29 | 第一季业绩 | 无派息 |
2024/03/25 | 末期业绩 | 股息:人民币 0.8700 (约相等于 0.956 港元) |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.